RCMI Coordinating Center (RCMI CC) Header Logo

Rajesh Singh

Title
Faculty RankAssociate Professor
InstitutionMorehouse School of Medicine
DepartmentMicrobiology, Biochemistry, & Immunology
Address720 Westveiw Drive, SW
Atlanta GA 30310
Phone4047526661
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    SC1CA193758     (SINGH, RAJESH)Sep 1, 2014 - Aug 31, 2021
    NIH
    Targeted Nanotherapy for prostate cancer
    Role: Principal Investigator

    R01CA256724     (SINGH, SHAILESH)Jul 1, 2022 - Dec 31, 2027
    NIH
    The interplay of social and molecular determinants in lung cancer disparity
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Afaq F, Pathi SS, Chakravarthi BVSK, Chandrashekar DS, Carskadon S, Diffalha SA, Kunju LP, Palanisamy N, Manne U, Singh R, Varambally S. AAA ATPase TRIP13 is overexpressed in prostate cancer and promotes tumor progression. Transl Oncol. 2026 Jun; 68:102743. PMID: 42000600.
      Citations:    
    2. Kinnel B, Srivastava AK, Singh SK, Singh R. In Silico and In Vitro Profiling of Honokiol and Paclitaxel-Loaded PBM Nanoparticles for Targeted Breast Cancer Delivery. Pharmaceuticals (Basel). 2025 Nov 27; 18(12). PMID: 41471303.
      Citations:    
    3. Srivastav AK, Singh A, Singh S, Rivers B, Lillard JW, Singh R. Revolutionizing Oncology Through AI: Addressing Cancer Disparities by Improving Screening, Treatment, and Survival Outcomes via Integration of Social Determinants of Health. Cancers (Basel). 2025 Aug 31; 17(17). PMID: 40940963.
      Citations:    
    4. Srivastav AK, Mishra MK, Lillard JW, Singh R. Transforming Pharmacogenomics and CRISPR Gene Editing with the Power of Artificial Intelligence for Precision Medicine. Pharmaceutics. 2025 Apr 24; 17(5). PMID: 40430848.
      Citations:    
    5. Srivastav AK, Jaiswal J, Rajput PK, Yadav UCS, Singh R, Kumar U. In silico and in vitro profiling of sphingomyelin loaded zein nanoconstructs with optimized aromatic interactions and pharmacokinetics for colon cancer therapeutics. Int J Biol Macromol. 2025 May; 307(Pt 1):141845. PMID: 40057096.
      Citations:    Fields:    Translation:HumansAnimalsCells
    6. Carey KM, Young CD, Clark AJ, Dammer EB, Singh R, Lillard JW. Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironment. J Ovarian Res. 2024 Dec 03; 17(1):240. PMID: 39627836.
      Citations: 2     Fields:    Translation:HumansCells
    7. Clark AJ, Singh R, Leonis RL, Stahlberg EA, Clark ZS, Lillard JW. Gene Co-Expression Network Analysis Associated with Endometrial Cancer Tumorigenesis and Survival Outcomes. Int J Mol Sci. 2024 Nov 18; 25(22). PMID: 39596419.
      Citations: 2     Fields:    Translation:Humans
    8. Kaur P, Singh SK, Mishra MK, Singh S, Singh R. Nanotechnology for boosting ovarian cancer immunotherapy. J Ovarian Res. 2024 Oct 14; 17(1):202. PMID: 39402681.
      Citations: 6     Fields:    Translation:Humans
    9. Kaur P, Singh SK, Mishra MK, Singh S, Singh R. Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer. Cancers (Basel). 2024 Jun 12; 16(12). PMID: 38927911.
      Citations:    
    10. Talukdar S, Singh SK, Mishra MK, Singh R. Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy. Nanomaterials (Basel). 2024 Jun 05; 14(11). PMID: 38869601.
      Citations:    
    11. Brock BA, Mir H, Flenaugh EL, Oprea-Ilies G, Singh R, Singh S. Social and Biological Determinants in Lung Cancer Disparity. Cancers (Basel). 2024 Jan 31; 16(3). PMID: 38339362.
      Citations:    
    12. McFadden M, Singh SK, Kinnel B, Varambally S, Singh R. The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer. J Ovarian Res. 2023 Nov 21; 16(1):220. PMID: 37990267.
      Citations: 11     Fields:    Translation:HumansCells
    13. McKinney LP, Singh R, Jordan IK, Varambally S, Dammer EB, Lillard JW. Transcriptome Analysis Identifies Tumor Immune Microenvironment Signaling Networks Supporting Metastatic Castration-Resistant Prostate Cancer. Onco (Basel). 2023 Jun; 3(2):81-95. PMID: 38435029.
      Citations:    
    14. Kinnel B, Singh SK, Oprea-Ilies G, Singh R. Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer. Cancers (Basel). 2023 Feb 19; 15(4). PMID: 36831661.
      Citations:    
    15. Singh SK, Singh R. Nanotherapy: targeting the tumour microenvironment. Nat Rev Cancer. 2022 05; 22(5):258. PMID: 35236941.
      Citations: 14     Fields:    Translation:Humans
    16. Adebayo OO, Dammer EB, Dill CD, Adebayo AO, Oseni SO, Griffen TL, Ohandjo AQ, Yan F, Jain S, Barwick BG, Singh R, Boise LH, Lillard JW. Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. Cancers (Basel). 2022 Apr 29; 14(9). PMID: 35565356.
      Citations:    
    17. Singh SK, Singh R. Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19. Cells. 2022 02 08; 11(3). PMID: 35159388.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    18. Haynes T, Oprea-Ilies G, Manne U, Singh R, Singh S, Mir H. The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity. Transl Oncol. 2022 Feb; 16:101330. PMID: 34990909.
      Citations:    
    19. Singh SK, Singh R. Surface Plasmon Resonance, a Novel Technique for Sensing Cancer Biomarker: Folate Receptor and Nanoparticles Interface. Methods Mol Biol. 2022; 2413:211-228. PMID: 35044668.
      Citations: 1     Fields:    Translation:Humans
    20. McFadden M, Singh SK, Oprea-Ilies G, Singh R. Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers. Cancers (Basel). 2021 Oct 31; 13(21). PMID: 34771642.
      Citations:    
    21. Singh SK, Singh S, Singh R. Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia. J Ovarian Res. 2021 Sep 27; 14(1):126. PMID: 34579761.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    22. Singh SK, Apata T, Singh S, McFadden M, Singh R. Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer. Biomedicines. 2021 Aug 16; 9(8). PMID: 34440224.
      Citations:    
    23. Mir H, Kapur N, Gales DN, Sharma PK, Oprea-Ilies G, Johnson AT, Singh R, Singh S. CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling. Cancers (Basel). 2021 Jul 16; 13(14). PMID: 34298782.
      Citations:    
    24. Singh SK, Gordetsky JB, Bae S, Acosta EP, Lillard JW, Singh R. Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer. Cells. 2020 08 27; 9(9). PMID: 32867229.
      Citations: 19     Fields:    Translation:HumansCells
    25. Yadav A, Jayaprakash PK, Singh R, Dawer M, Modi P, Sehdev B, Ganji KK. Impact of recycling on the mechanical properties of nickel-titanium alloy wires and the efficacy of their reuse after cold sterilization. J Orthod Sci. 2020; 9:10. PMID: 33354536.
      Citations:    
    26. Ukwade CE, Ebuehi OAT, Adisa RA, Singh SK, Singh R. Anti-proliferative activities of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae) using ovarian cancer cell lines. J Ovarian Res. 2020 Jul 21; 13(1):83. PMID: 32693841.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    27. Darling HS, Viswanath S, Singh R, Ranjan S, Pathi N, Rathore A, Pathak A, Sud R. A clinico-epidemiological, pathological, and molecular study of lung cancer in Northwestern India. J Cancer Res Ther. 2020 Jul-Sep; 16(4):771-779. PMID: 32930117.
      Citations: 4     Fields:    Translation:Humans
    28. Singh SK, Mishra MK, Rivers BM, Gordetsky JB, Bae S, Singh R. Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma. Cancers (Basel). 2020 Apr 05; 12(4). PMID: 32260550.
      Citations:    
    29. Noel B, Singh SK, Lillard JW, Singh R. Role of natural compounds in preventing and treating breast cancer. Front Biosci (Schol Ed). 2020 03 01; 12(1):137-160. PMID: 32114452.
      Citations: 26     Fields:    Translation:HumansAnimals
    30. Singh SK, Singh R. Liver cancer incidence and mortality: Disparities based on age, ethnicity, health and nutrition, molecular factors, and geography. Cancer Health Disparities. 2020 Mar; 4:e1-e10. PMID: 34164612.
      Citations:    
    31. Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020 01; 1873(1):188314. PMID: 31682895.
      Citations: 743     Fields:    Translation:Humans
    32. Singh SK, Apata T, Gordetsky JB, Singh R. Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway. Cancers (Basel). 2019 Sep 18; 11(9). PMID: 31540423.
      Citations:    
    33. Singh R, Jayaprakash PK, Yadav A, Dawar M, Grewal H, Mishra A. Evaluation of levels of Interleukin-1b, intensity of pain and tooth movement during canine retraction using different magnitudes of continuous orthodontic force. J Family Med Prim Care. 2019 Jul; 8(7):2373-2377. PMID: 31463260.
      Citations:    
    34. Singh SK, Mishra MK, Singh R. Hypoxia-inducible factor-1a induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells. J Ovarian Res. 2019 May 10; 12(1):42. PMID: 31077234.
      Citations: 19     Fields:    Translation:HumansCells
    35. Garg SK, Sarvepalli S, Campbell JP, Obaitan I, Singh D, Bazerbachi F, Singh R, Sanaka MR. Incidence, Admission Rates, and Predictors, and Economic Burden of Adult Emergency Visits for Acute Pancreatitis: Data From the National Emergency Department Sample, 2006 to 2012. J Clin Gastroenterol. 2019 03; 53(3):220-225. PMID: 29629907.
      Citations: 36     Fields:    Translation:Humans
    36. Garg SK, Sarvepalli S, Campbell JP, Anugwom C, Singh D, Wadhwa V, Singh R, Sanaka MR. Incidence and Predictors of 30-Day Readmission Among Patients Hospitalized for Chronic Pancreatitis. Pancreas. 2018 09; 47(8):1008-1014. PMID: 30059472.
      Citations: 1     Fields:    Translation:Humans
    37. Singh SK, Lillard JW, Singh R. Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. Cancer Lett. 2018 07 28; 427:49-62. PMID: 29678549.
      Citations: 48     Fields:    Translation:HumansCells
    38. Singh SK, Mishra MK, Eltoum IA, Bae S, Lillard JW, Singh R. CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells. Sci Rep. 2018 01 22; 8(1):1323. PMID: 29358632.
      Citations: 109     Fields:    Translation:HumansCells
    39. Garg SK, Campbell JP, Anugwom C, Wadhwa V, Singh R, Gupta N, Sanaka MR. Incidence and Predictors of Readmissions in Acute Pancreatitis: A Nationwide Analysis. Pancreas. 2018 01; 47(1):46-54. PMID: 29215534.
      Citations: 19     Fields:    Translation:Humans
    40. Singh R, Mishra MK, Aggarwal H. Inflammation, Immunity, and Cancer. Mediators Inflamm. 2017; 2017:6027305. PMID: 29234189.
      Citations: 133     Fields:    Translation:HumansAnimals
    41. Akpalu D, Newman G, Brice M, Powell M, Singh R, Quarshie A, Ofili E, Fonger J, Chronos N, Feldman D. Matrix Signaling Subsequent to a?Myocardial Infarction: A Proteomic Profile of Tissue Factor Microparticles. JACC Basic Transl Sci. 2017 Oct; 2(5):529-542. PMID: 30062169.
      Citations:    
    42. Singh SK, Singh S, Lillard JW, Singh R. Drug delivery approaches for breast cancer. Int J Nanomedicine. 2017; 12:6205-6218. PMID: 28883730.
      Citations: 75     Fields:    Translation:Humans
    43. Dutta V, Singh R, Kumar S, Aggarwal N, Hari Kumar KVS. Profile of pulmonary embolism in service personnel posted at high altitude area. Indian Heart J. 2018 May - Jun; 70(3):427-429. PMID: 29961462.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    44. Singh SK, Banerjee S, Acosta EP, Lillard JW, Singh R. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget. 2017 Mar 07; 8(10):17216-17228. PMID: 28212547.
      Citations: 115     Fields:    Translation:HumansCells
    45. Banerjee S, Singh SK, Chowdhury I, Lillard JW, Singh R. Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. Front Biosci (Elite Ed). 2017 03 01; 9(2):235-245. PMID: 28199187.
      Citations: 48     Fields:    Translation:HumansCells
    46. Singh SK, Lillard JW, Singh R. Molecular basis for prostate cancer racial disparities. Front Biosci (Landmark Ed). 2017 01 01; 22(3):428-450. PMID: 27814623.
      Citations: 18     Fields:    Translation:Humans
    47. Singh R, Kapur N, Mir H, Singh N, Lillard JW, Singh S. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and av?3 integrin clustering. Oncotarget. 2016 Feb 09; 7(6):7343-53. PMID: 26799186.
      Citations: 40     Fields:    Translation:HumansCells
    48. Mir H, Kapur N, Singh R, Sonpavde G, Lillard JW, Singh S. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors. Cell Cycle. 2016; 15(6):819-26. PMID: 27029529.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    49. Omosun Y, McKeithen D, Ryans K, Kibakaya C, Blas-Machado U, Li D, Singh R, Inoue K, Xiong ZG, Eko F, Black C, Igietseme J, He Q. Interleukin-10 modulates antigen presentation by dendritic cells through regulation of NLRP3 inflammasome assembly during Chlamydia infection. Infect Immun. 2015 Dec; 83(12):4662-72. PMID: 26371131.
      Citations: 24     Fields:    Translation:AnimalsCells
    50. Mir H, Singh R, Kloecker GH, Lillard JW, Singh S. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases. Oncotarget. 2015 Apr 30; 6(12):9985-98. PMID: 25888629.
      Citations: 18     Fields:    Translation:HumansCells
    51. Gupta P, Sharma PK, Mir H, Singh R, Singh N, Kloecker GH, Lillard JW, Singh S. CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis. Oncotarget. 2014 Oct 30; 5(20):10170-9. PMID: 25296976.
      Citations: 31     Fields:    Translation:HumansCells
    52. Singh R, Gupta P, Kloecker GH, Singh S, Lillard JW. Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma. Int J Oncol. 2014 Dec; 45(6):2232-40. PMID: 25271023.
      Citations: 49     Fields:    Translation:HumansCells
    53. Kumar M, Maheshwari A, Lall R, Navit P, Singh R, Navit S. Comparative Evaluation of Shear Bond Strength of Recycled Brackets using Different Methods: An In vitro Study. J Int Oral Health. 2014 Sep; 6(5):5-11. PMID: 25395785.
      Citations:    
    54. Singh R, Gupta P, Sharma PK, Ades EW, Hollingshead SK, Singh S, Lillard JW. Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A. Immunology. 2014 Apr; 141(4):514-30. PMID: 24138116.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    55. Gupta D, Bhaskar DJ, Gupta RK, Karim B, Jain A, Singh R, Karim W. A randomized controlled clinical trial of Ocimum sanctum and chlorhexidine mouthwash on dental plaque and gingival inflammation. J Ayurveda Integr Med. 2014 Apr; 5(2):109-16. PMID: 24948862.
      Citations:    
    56. El-Haibi CP, Sharma P, Singh R, Gupta P, Taub DD, Singh S, Lillard JW. Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5. Mol Cancer. 2013 Jun 18; 12:64. PMID: 23773523.
      Citations: 30     Fields:    Translation:HumansCells
    57. Akama T, Virtucio C, Dong C, Kimura R, Zhang YK, Nieman JA, Sharma R, Lu X, Sales M, Singh R, Wu A, Fan XQ, Liu L, Plattner JJ, Jarnagin K, Freund YR. Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent. Bioorg Med Chem Lett. 2013 Mar 15; 23(6):1680-3. PMID: 23411072.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    58. Hernandez V, Cr?pin T, Palencia A, Cusack S, Akama T, Baker SJ, Bu W, Feng L, Freund YR, Liu L, Meewan M, Mohan M, Mao W, Rock FL, Sexton H, Sheoran A, Zhang Y, Zhang YK, Zhou Y, Nieman JA, Anugula MR, Keramane el M, Savariraj K, Reddy DS, Sharma R, Subedi R, Singh R, O'Leary A, Simon NL, De Marsh PL, Mushtaq S, Warner M, Livermore DM, Alley MR, Plattner JJ. Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria. Antimicrob Agents Chemother. 2013 Mar; 57(3):1394-403. PMID: 23295920.
      Citations: 101     Fields:    Translation:HumansAnimalsCells
    59. Freund YR, Akama T, Alley MR, Antunes J, Dong C, Jarnagin K, Kimura R, Nieman JA, Maples KR, Plattner JJ, Rock F, Sharma R, Singh R, Sanders V, Zhou Y. Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center. FEBS Lett. 2012 Sep 21; 586(19):3410-4. PMID: 22841723.
      Citations: 32     Fields:    Translation:HumansCells
    60. Borgegard T, Jur?us A, Olsson F, Rosqvist S, Sabirsh A, Rotticci D, Paulsen K, Klintenberg R, Yan H, Waldman M, Stromberg K, Nord J, Johansson J, Regner A, Parpal S, Malinowsky D, Radesater AC, Li T, Singh R, Eriksson H, Lundkvist J. First and second generation ?-secretase modulators (GSMs) modulate amyloid-? (A?) peptide production through different mechanisms. J Biol Chem. 2012 Apr 06; 287(15):11810-9. PMID: 22334705.
      Citations: 36     Fields:    Translation:HumansAnimalsCells
    61. El-Haibi CP, Singh R, Gupta P, Sharma PK, Greenleaf KN, Singh S, Lillard JW. Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer. J Proteomics Bioinform. 2012; 5(8):177-184. PMID: 24009409.
      Citations:    
    62. Singh R, Singh S, Briles DE, Taub DD, Hollingshead SK, Lillard JW. CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes. Vaccine. 2012 Feb 01; 30(6):1181-90. PMID: 22178100.
      Citations: 1     Fields:    Translation:AnimalsCells
    63. Moktar A, Singh R, Vadhanam MV, Ravoori S, Lillard JW, Gairola CG, Gupta RC. Cigarette smoke condensate-induced oxidative DNA damage and its removal in human cervical cancer cells. Int J Oncol. 2011 Oct; 39(4):941-7. PMID: 21720711.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    64. El-Haibi CP, Singh R, Sharma PK, Singh S, Lillard JW. CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation. Cell Prolif. 2011 Aug; 44(4):311-9. PMID: 21645150.
      Citations: 51     Fields:    Translation:HumansCells
    65. Singh R, Lillard JW, Singh S. Chemokines: key players in cancer progression and metastasis. Front Biosci (Schol Ed). 2011 06 01; 3(4):1569-82. PMID: 21622291.
      Citations: 41     Fields:    Translation:Humans
    66. Singh R, Stockard CR, Grizzle WE, Lillard JW, Singh S. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer. Int J Oncol. 2011 Aug; 39(2):373-81. PMID: 21637913.
      Citations: 35     Fields:    Translation:HumansCells
    67. Shankar E, Vykhovanets EV, Vykhovanets OV, Maclennan GT, Singh R, Bhaskaran N, Shukla S, Gupta S. High-fat diet activates pro-inflammatory response in the prostate through association of Stat-3 and NF-?B. Prostate. 2012 Feb; 72(3):233-43. PMID: 21604287.
      Citations: 36     Fields:    Translation:AnimalsCells
    68. Johnson-Holiday C, Singh R, Johnson EL, Grizzle WE, Lillard JW, Singh S. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion. World J Surg Oncol. 2011 May 03; 9:46. PMID: 21539750.
      Citations: 28     Fields:    Translation:HumansCells
    69. Johnson-Holiday C, Singh R, Johnson E, Singh S, Stockard CR, Grizzle WE, Lillard JW. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. Int J Oncol. 2011 May; 38(5):1279-85. PMID: 21344163.
      Citations: 50     Fields:    Translation:HumansCells
    70. Johnson EL, Singh R, Singh S, Johnson-Holiday CM, Grizzle WE, Partridge EE, Lillard JW. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. World J Surg Oncol. 2010 Jul 22; 8:62. PMID: 20649989.
      Citations: 25     Fields:    Translation:HumansCells
    71. Johnson EL, Singh R, Johnson-Holiday CM, Grizzle WE, Partridge EE, Lillard JW, Singh S. CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion. J Ovarian Res. 2010 Jun 17; 3:15. PMID: 20565782.
      Citations: 21     Fields:    
    72. El Haibi CP, Sharma PK, Singh R, Johnson PR, Suttles J, Singh S, Lillard JW. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells. Mol Cancer. 2010 Apr 22; 9:85. PMID: 20412587.
      Citations: 34     Fields:    Translation:HumansCells
    73. VanCleave TT, Moore JH, Benford ML, Brock GN, Kalbfleisch T, Baumgartner RN, Lillard JW, Kittles RA, Kidd LC. Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate. 2010 Mar 01; 70(4):341-52. PMID: 19908237.
      Citations: 26     Fields:    Translation:Humans
    74. Singh R, Singh S, Sharma PK, Singh UP, Briles DE, Hollingshead SK, Lillard JW. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A. PLoS One. 2010 Feb 25; 5(2):e9432. PMID: 20195541.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    75. Singh S, Singh R, Singh UP, Rai SN, Novakovic KR, Chung LW, Didier PJ, Grizzle WE, Lillard JW. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. Int J Cancer. 2009 Nov 15; 125(10):2288-95. PMID: 19610059.
      Citations: 41     Fields:    Translation:HumansCells
    76. Singh S, Singh R, Sharma PK, Singh UP, Rai SN, Chung LW, Cooper CR, Novakovic KR, Grizzle WE, Lillard JW. Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett. 2009 Sep 28; 283(1):29-35. PMID: 19375853.
      Citations: 55     Fields:    Translation:HumansCells
    77. Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009 Jun; 86(3):215-23. PMID: 19186176.
      Citations: 631     Fields:    Translation:HumansAnimals
    78. Hutchings KM, Tran TP, Ellsworth EL, Watson BM, Sanchez JP, Showalter HD, Stier MA, Shapiro M, Themis Joannides E, Huband M, Nguyen DQ, Maiti S, Li T, Tailor J, Thomas G, Ha C, Singh R. Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones. Bioorg Med Chem Lett. 2008 Sep 15; 18(18):5087-90. PMID: 18752951.
      Citations: 7     Fields:    Translation:Cells
    79. Singh R, Singh S, Lillard JW. Past, present, and future technologies for oral delivery of therapeutic proteins. J Pharm Sci. 2008 Jul; 97(7):2497-523. PMID: 17918721.
      Citations: 38     Fields:    Translation:Cells
    80. Singh UP, Singh R, Singh S, Karls RK, Quinn FD, Taub DD, Lillard JW. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. BMC Immunol. 2008 Jun 04; 9:25. PMID: 18533024.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    81. Singh UP, Singh S, Singh R, Cong Y, Taub DD, Lillard JW. CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. J Interferon Cytokine Res. 2008 Jan; 28(1):31-43. PMID: 18370870.
      Citations: 34     Fields:    Translation:AnimalsCells
    82. Zuba-Surma EK, Kucia M, Abdel-Latif A, Dawn B, Hall B, Singh R, Lillard JW, Ratajczak MZ. Morphological characterization of very small embryonic-like stem cells (VSELs) by ImageStream system analysis. J Cell Mol Med. 2008 Jan-Feb; 12(1):292-303. PMID: 18031297.
      Citations: 51     Fields:    Translation:AnimalsCells
    83. Singh UP, Venkataraman C, Singh R, Lillard JW. CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr Metab Immune Disord Drug Targets. 2007 Jun; 7(2):111-23. PMID: 17584151.
      Citations: 54     Fields:    Translation:HumansAnimals
    84. Singh UP, Singh S, Singh R, Karls RK, Quinn FD, Potter ME, Lillard JW. Influence of Mycobacterium avium subsp. paratuberculosis on colitis development and specific immune responses during disease. Infect Immun. 2007 Aug; 75(8):3722-8. PMID: 17502388.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    85. Tran TP, Ellsworth EL, Sanchez JP, Watson BM, Stier MA, Showalter HD, Domagala JM, Shapiro MA, Joannides ET, Gracheck SJ, Nguyen DQ, Bird P, Yip J, Sharadendu A, Ha C, Ramezani S, Wu X, Singh R. Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors. Bioorg Med Chem Lett. 2007 Mar 01; 17(5):1312-20. PMID: 17196390.
      Citations: 19     Fields:    Translation:Cells
    86. Ellsworth EL, Tran TP, Showalter HD, Sanchez JP, Watson BM, Stier MA, Domagala JM, Gracheck SJ, Joannides ET, Shapiro MA, Dunham SA, Hanna DL, Huband MD, Gage JW, Bronstein JC, Liu JY, Nguyen DQ, Singh R. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms. J Med Chem. 2006 Nov 02; 49(22):6435-8. PMID: 17064062.
      Citations: 18     Fields:    Translation:Cells
    87. Palaniappan R, Singh S, Singh UP, Singh R, Ades EW, Briles DE, Hollingshead SK, Royal W, Sampson JS, Stiles JK, Taub DD, Lillard JW. CCL5 modulates pneumococcal immunity and carriage. J Immunol. 2006 Feb 15; 176(4):2346-56. PMID: 16455992.
      Citations: 23     Fields:    Translation:AnimalsCells
    88. Tran TP, Ellsworth EL, Stier MA, Domagala JM, Showalter HD, Gracheck SJ, Shapiro MA, Joannides TE, Singh R. Synthesis and structural-activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents. Bioorg Med Chem Lett. 2004 Sep 06; 14(17):4405-9. PMID: 15357962.
      Citations: 7     Fields:    
    Singh's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (402)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support